Genomics has transformed biomedical science. But what is its place in public health - a field traditionally rooted in sanitation, vaccination, and social reform?

In this chapter, we explore how genomic science intersects with population health. Advances in sequencing technologies have made it possible to identify genetic susceptibility to disease, understand pathogen evolution, and develop targeted therapies.

We examine the promise and the limits of genomic integration into public health practice. While genomics enables personalised medicine and improved screening, most population-level disease burden remains shaped by social and environmental determinants.

The chapter addresses key ethical and policy questions: equity of access to genomic technologies, privacy concerns, data governance, discrimination risks, and the allocation of resources between high-tech innovation and basic public health infrastructure.

We also consider the role of genomics in infectious disease control - particularly in outbreak tracking and antimicrobial resistance monitoring.

Genomics expands the toolkit of public health - but it does not replace its foundational commitments to equity, prevention, and systems thinking.

Key Takeaways

* Genomics enhances understanding of disease susceptibility and transmission.

* Most common diseases result from gene–environment interaction.

* Public health impact depends on equitable access to genomic technologies.

* Ethical issues include privacy, discrimination, and consent.

* Genomic screening must be evidence-based and proportionate.

* Infectious disease genomics supports outbreak control.

* Resource allocation between high-technology and basic services requires balance.

* Genomics complements but does not substitute structural interventions.

In many developing countries, health inequalities are both stark and visible. Maternal mortality, child survival, infectious disease burden, and malnutrition disproportionately affect the poorest, rural populations, and marginalised groups.

This chapter moves from describing inequality to confronting how it can be reduced. It examines the structural drivers of disparity - poverty, weak infrastructure, limited education, gender inequity, political instability, and underfunded health systems.

We explore strategies that have demonstrated measurable impact: expansion of primary healthcare, immunisation campaigns, conditional cash transfers, community health worker programmes, improved water and sanitation systems, and targeted maternal and child health interventions.

The chapter also discusses governance and financing. Domestic resource mobilisation, fair taxation, donor alignment, and accountability mechanisms determine whether inequality reduction efforts are sustained or fragmented.

Importantly, reducing inequality requires deliberate prioritisation of the most disadvantaged - not simply expanding services in aggregate.

Equity does not emerge automatically from growth. It requires design.

Key Takeaways

* Health inequalities in developing countries are often extreme and visible.

* Rural, poor, and marginalised populations bear disproportionate burdens.

* Strengthening primary healthcare is central to equity improvement.

* Community-based interventions can bridge geographic and social gaps.

* Social protection policies can indirectly improve health outcomes.

* Governance quality strongly influences programme success.

* Targeted maternal and child health strategies reduce mortality gaps.

* Sustainable progress requires long-term financing commitments.

High-income countries are often assumed to have solved the major health challenges of poverty and infectious disease. Yet stark socioeconomic inequalities in health persist - even within the most affluent societies.

In this chapter, we examine the empirical evidence demonstrating health gradients across income, education, occupation, and neighbourhood status in developed countries. Life expectancy, cardiovascular disease, cancer outcomes, mental health disorders, and infant mortality all vary systematically along social lines.

The episode explores the mechanisms underlying these gradients: material deprivation, psychosocial stress, occupational exposure, behavioural risk patterns shaped by context, and access differentials within health systems.

Importantly, we analyse policy responses. Should interventions focus on the most disadvantaged groups, or aim to reduce the gradient across the whole population? The debate between targeted approaches and proportionate universalism becomes central.

We also consider political feasibility. Evidence alone does not drive change; public support, economic narratives, and institutional structures influence whether inequality reduction strategies are adopted.

This chapter reinforces a critical lesson: inequality is not eliminated by economic growth alone. It requires deliberate, sustained policy design.

Key Takeaways

* Significant health gradients persist within high-income countries.

* Inequalities affect both morbidity and mortality.

* Social position influences exposure, vulnerability, and recovery.

* Psychosocial stress contributes independently to disease risk.

* Universal systems may still produce unequal outcomes.

* Targeted vs population-wide approaches remain debated.

* Proportionate universalism aims to combine fairness with efficiency.

* Reducing inequality requires cross-sector policy intervention.

Poverty is not simply a lack of income. It is a powerful predictor of life expectancy, child survival, chronic disease, and mental health. It shapes exposure, vulnerability, and access to care.

In this chapter, we examine the relationship between poverty and health through the lens of justice. Health disparities are not random - they follow social gradients. Those lower on the socioeconomic ladder experience higher mortality, greater morbidity, and shorter lives.

We explore how poverty operates through multiple pathways: inadequate housing, food insecurity, environmental exposure, limited education, insecure employment, psychosocial stress, and restricted healthcare access. Health inequalities are produced through cumulative disadvantage across the life course.

The chapter also engages with ethical frameworks. Are health inequalities inevitable? When do differences become unjust? The distinction between inequality and inequity becomes central - inequities are avoidable, unfair, and rooted in structural arrangements.

Addressing poverty-related health disparities requires policy beyond healthcare - taxation, labour markets, education systems, housing policy, and social protection.

This episode challenges us to see health inequity not merely as a technical problem, but as a moral one.

Key Takeaways

* Poverty is a major determinant of health outcomes across populations.

* Health follows a social gradient - not only the poorest are affected.

* Material deprivation and psychosocial stress both contribute to disease.

* Inequality becomes inequity when it is avoidable and unjust.

* Structural policies strongly influence health distribution.

* Interventions must address root economic and social conditions.

* Life course disadvantage compounds health risk.

* Equity-focused public health requires political commitment.

Health does not begin in hospitals. It begins in homes, schools, workplaces, neighbourhoods, and policy chambers.

In this foundational chapter of Section 2, we explore the concept of health determinants - the broad constellation of factors that shape population health outcomes. Moving beyond individual risk factors, this framework situates health within nested layers of influence: biological, behavioural, social, economic, environmental, and political.

We examine classical models of health determinants, including ecological frameworks that depict health as the product of interacting systems rather than isolated exposures. Income, education, employment, housing, food security, environmental quality, social cohesion, and access to healthcare are not peripheral - they are central.

The chapter emphasises the distinction between proximal causes (such as smoking or diet) and upstream determinants (such as poverty, marketing systems, urban design, and governance structures). Effective public health strategy requires addressing root causes rather than only their downstream manifestations.

Understanding determinants reframes responsibility. Illness is not solely the result of personal choices; it is shaped by structural context.

This episode lays the conceptual groundwork for analysing inequality, climate change, commercial influences, and access to care in subsequent chapters.

Key Takeaways

* Health outcomes arise from multiple interacting determinants.

* Determinants operate at biological, behavioural, social, environmental, and political levels.

* Upstream structural factors often drive downstream risk behaviours.

* Socioeconomic conditions strongly predict morbidity and mortality.

* Health is shaped by policy decisions across sectors.

* Ecological models provide a systems-based understanding of causation.

* Addressing determinants requires intersectoral collaboration.

* Prevention efforts are more sustainable when root causes are targeted.

Globalization has fundamentally altered the landscape of public health. Diseases, goods, information, capital, and people now move across borders at unprecedented speed. What once remained local is now global within hours.

In this episode, we explore how globalization reshapes determinants of health, patterns of disease, governance structures, and policy authority. Infectious diseases spread through global travel networks. Non-communicable diseases are exported through global food systems, tobacco marketing, and commercial expansion. Environmental harms transcend national boundaries.

We examine the role of multinational corporations, global trade agreements, migration flows, and digital connectivity in shaping health outcomes. Health systems increasingly operate within global supply chains, financing mechanisms, and regulatory regimes.

Globalization also introduces new governance challenges. National sovereignty must coexist with international coordination. Instruments such as the International Health Regulations and global health treaties illustrate how law attempts to manage shared risks.

Yet globalization is not solely a threat. It enables rapid scientific collaboration, vaccine development, global advocacy movements, and transnational solidarity.

Public health is no longer confined within national borders. It is negotiated in global arenas of power, commerce, diplomacy, and information.

Key Takeaways

* Globalization accelerates disease transmission across borders.

* Commercial determinants of health operate transnationally.

* Trade, migration, and environmental change influence population health.

* Global governance mechanisms shape national health policy.

* Multinational corporations significantly affect health environments.

* Digital technologies transform health communication and surveillance.

* Global collaboration can accelerate innovation and crisis response.

* Health equity challenges extend beyond national policy frameworks.

Middle-income countries occupy a uniquely complex position in global public health. No longer classified as low-income, yet far from fully industrialised welfare states, these nations experience rapid economic growth alongside persistent inequality.

In this episode, we explore how public health evolves during economic transition. Industrial expansion, urban migration, demographic change, and rising incomes reshape disease patterns. Infectious diseases may decline - but non-communicable diseases surge. The epidemiological transition becomes visible in real time.

We examine the “double burden” of disease - where tuberculosis and maternal mortality coexist with diabetes, cardiovascular disease, and obesity. Health systems must stretch across prevention, treatment, chronic care management, and emerging technological demands.

Economic transition also transforms governance. Expanding private healthcare markets, insurance reforms, and decentralised systems introduce new regulatory challenges. Environmental degradation, occupational hazards, and air pollution accompany industrial growth.

This chapter highlights the policy dilemmas of transition: how to invest limited resources wisely, how to build equitable systems during growth, and how to avoid widening health gaps.

Economic development alone does not guarantee health equity. Without deliberate policy, prosperity can amplify disparity.

Key Takeaways

* Middle-income countries face rapid epidemiological transition.

* The double burden of infectious and non-communicable disease creates system strain.

* Urbanisation introduces environmental and occupational health challenges.

* Economic growth can widen health inequities if not paired with redistributive policy.

* Expanding private sectors require strong regulatory frameworks.

* Health financing reforms are central to sustainable transition.

* Demographic shifts (ageing populations) alter service demand.

* Public health strategy during transition requires anticipatory governance.

Public health in low- and middle-income countries (LMICs) followed a markedly different trajectory from that of industrialised nations. While European public health evolved alongside domestic urban reform, much of public health infrastructure in LMICs emerged within colonial systems - often designed to protect colonial interests rather than indigenous populations.

In this episode, we explore how colonial medicine prioritised port cities, military personnel, and economic productivity. Disease control efforts frequently targeted threats to trade and governance, rather than broader population health.

With decolonisation in the mid-twentieth century came an ambitious reimagining of health systems. Newly independent nations confronted infectious disease burdens, fragile infrastructures, workforce shortages, and limited fiscal capacity. The Alma-Ata Declaration of 1978 marked a pivotal moment, advocating primary healthcare as the foundation for equitable development.

We examine tensions between vertical disease programmes (focused, externally funded initiatives such as malaria or HIV control) and horizontal system strengthening approaches. Structural adjustment policies, global financing institutions, and donor agendas shaped health system trajectories in complex ways.

This chapter reminds us that global public health cannot be understood without confronting history - particularly the legacies of inequality, dependency, and economic constraint.

Public health development in LMICs is not a lesser version of the Western story. It is a distinct narrative shaped by geopolitics, economics, and global power.

Key Takeaways

* Colonial health systems often prioritised economic and political interests over equity.

* Decolonisation created opportunities and structural challenges for national health development.

* Primary healthcare emerged as a transformative global vision in Alma-Ata.

* Vertical disease programmes can produce rapid gains but risk fragmenting systems.

* Health system strengthening requires workforce, financing, governance, and infrastructure investment.

* Global institutions and donor priorities significantly influence national health strategies.

* Historical inequities continue to shape present-day health disparities.

* Understanding LMIC public health requires analysing political economy, not only epidemiology.

Public health did not emerge in lecture theatres. It emerged in overcrowded cities, in the shadow of epidemics, and in response to social upheaval.

In this episode, we trace the development of public health in high-income countries - from the sanitary movement of the nineteenth century to the institutionalisation of welfare states in the twentieth. We explore how industrialisation, urbanisation, and poverty created conditions for infectious disease outbreaks, and how reformers used data, political advocacy, and engineering solutions to transform cities.

Figures such as Edwin Chadwick and John Snow symbolise two essential public health tools: structural reform and epidemiological reasoning. The sanitary revolution - sewage systems, clean water, housing reform - dramatically reduced mortality long before antibiotics became available.

The episode then moves into the bacteriological era, where germ theory refined understanding of causation and catalysed vaccination programmes and surveillance systems. We examine how the expansion of state responsibility for health in the twentieth century laid foundations for national health systems, regulatory frameworks, and social protection policies.

Importantly, we also reflect on the tensions that accompanied this evolution - debates about state intervention, personal liberty, and the role of medicine versus prevention.

Public health in developed countries evolved through crisis, political negotiation, scientific advancement, and moral commitment to collective well-being. Its trajectory reveals a central lesson: progress in health is rarely accidental - it is constructed.

Key Takeaways

* Industrialisation and urbanisation were catalysts for modern public health systems.

* The sanitary movement preceded and outperformed early medical therapies in reducing mortality.

* Epidemiology emerged as a powerful investigative and advocacy tool.

* Germ theory refined causal understanding and strengthened prevention strategies.

* The rise of welfare states institutionalised public responsibility for health.

* Public health progress depended on political will as much as scientific evidence.

* Tensions between individual liberty and collective health are historically persistent.

* Developed country public health systems are products of social reform, not purely medical innovation.

In this opening episode of the Public Health series, we explore the intellectual and moral foundations of public health as a discipline. This chapter defines what public health is - and crucially, what it is not.

Public health moves beyond the clinic. It shifts the focus from treating individual disease to preventing illness, prolonging life, and promoting health at the population level. It asks different questions: not “Why did this patient develop disease?” but “Why do some populations experience higher rates of disease than others?”

We examine the historical evolution of public health - from sanitation reform and infectious disease control to the modern era of non-communicable disease, behavioural risk factors, and global health governance. The chapter introduces the core triad of public health functions: assessment, policy development, and assurance.

It also highlights the inherently interdisciplinary nature of public health. Epidemiology, biostatistics, sociology, economics, environmental science, political science, ethics, and law converge in a field that must operate within complex political systems and across sectors.

At its heart, public health is concerned with equity. It asks who is left behind - and why.

This episode lays the conceptual foundation for everything that follows in Season 12. Before we examine methods, policies, or diseases, we must first understand the scope - the breadth, ambition, and ethical commitments - of public health itself.

Key Takeaways

* Public health focuses on populations, not individual clinical encounters.

* Its core mission is prevention, health promotion, and prolongation of life.

* It operates across disciplines and sectors, not solely within healthcare systems.

* Health outcomes are shaped by social, economic, environmental, and political determinants.

* Public health requires systems thinking and long-term strategic vision.

* Equity is central: reducing avoidable and unjust differences in health is a defining goal.

* Public health action often requires balancing individual liberty with collective benefit.

* Effective public health requires leadership, governance, and evidence-informed policy.